Clinical Trial Update: A Clinical Study to Assess the Effects of SRT2104 Upon Immobilization-Induced Skeletal Muscle Atrophy in Healthy Human Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the effects of SRT2104 on immobilization-induced skeletal muscle atrophy in healthy volunteers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skeletal Muscle Atrophy

Drugs mentioned

• SRT2104 (SRT2104)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Healthy Volunteer, Atrophy, Muscular | Phase 1 | Status: WITHDRAWN